世界の細胞解析市場2023年-2032年:製品別(消耗品、サービス、機器、ソフトウェア)、技術別(フローサイトメトリー、質量分析、次世代シーケンシング(NGS)、ポリメラーゼ連鎖反応(PCR)、その他)、用途別(腫瘍学、免疫学、心臓病学、遺伝病、幹細胞、その他)、エンドユーザー別(バイオテクノロジー&製薬会社、病院&診断研究所、学術&研究機関、その他)

【英語タイトル】Cell Analysis Market By Product (Consumables, Services, Instruments, Software), By Technique (Flow cytometry, Mass Spectrometry, Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others), By Application (Oncology, Immunology, Cardiology, Genetic Disease, Stem Cells, Others), By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Academic and Research Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Allied Market Researchが出版した調査資料(ALD23SEP108)・商品コード:ALD23SEP108
・発行会社(調査会社):Allied Market Research
・発行日:2023年4月
・ページ数:249
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:生命科学
◆販売価格オプション(消費税別)
Online Only(1名閲覧、印刷不可)USD3,570 ⇒換算¥542,640見積依頼/購入/質問フォーム
Single User(1名閲覧)USD5,730 ⇒換算¥870,960見積依頼/購入/質問フォーム
Enterprise User(閲覧人数無制限)USD9,600 ⇒換算¥1,459,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

細胞解析市場は、2022年に171億ドルと評価され、2023年から2032年までの年平均成長率は9.5%で、2032年には429億ドルに達すると予測されています。細胞解析は、個々の細胞の構造、組成、挙動を観察、研究するために使用されます。顕微鏡、フローサイトメトリー、分光光度法、免疫測定法などのさまざまな技術を使用して、細胞の健康状態や活性に関する情報を取得します。病気の検出や診断、治療に対する反応のモニタリング、細胞機能のメカニズムの調査などに使用されます。
市場の成長を促す主な要因は、細胞解析における技術進歩の高まりと、癌や遺伝性疾患などの慢性疾患の有病率の増加です。例えば、世界保健機関(WHO)によると、がんは世界の主要な死因であり、2020年の死亡者数は約1,000万人です。2020年の患者数で最も多いのは乳がんで226万人、次いで肺がんで221万人です。2020年のがんによる死因で最も多いのは肺がんで180万人、次いで結腸・直腸がんで91万6,000人です。さらに、製薬・バイオテクノロジー業界における研究開発活動の急増と個別化医療への注目の高まりが、市場の成長をさらに後押ししています。しかし、細胞解析製品の高価格と熟練した専門家の不足が、今後数年間の市場成長の妨げになると予想されます。逆に、シングルセルシーケンスの高い成長可能性は、予測期間中に市場成長のための多くの機会を提供すると予想されます。

細胞解析市場は、製品、アプリケーション、技術、エンドユーザー、地域に区分されます。製品別では、市場は消耗品、ソフトウェア、サービス、機器に二分されます。アプリケーション別では、腫瘍学、免疫学、心臓学、幹細胞、遺伝病、その他に分類されます。技術別では、フローサイトメトリー、次世代シーケンシング(NGS)、ポリメラーゼ連鎖反応(PCR)、質量分析、その他に分類されます。エンドユーザー別では、学術・研究ラボ、バイオテクノロジー・製薬会社、病院・診断ラボ、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されます。
主要企業は、Becton, Dickinson and Company、Danaher Corporation、QIAGEN N.V.、Thermo Fisher Scientific, Inc.、Illumina, Inc.、Bio-Rad Laboratories、Agilent Technologies, Inc.、Sartorius AG、Biomerieux SA、Standard BioTools Inc.などです。同市場で事業を展開する主要企業は、企業研修市場シェアを拡大するための主要戦略として、製品発売、製品承認、コラボレーションを採用しています。

ステークホルダーにとっての主な利点
本レポートは、2022年から2032年までの細胞解析市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、細胞解析市場の有力な機会を特定します。
主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
細胞解析市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
各地域の主要国を、世界市場に対する収益貢献度に応じてマッピングしています。
市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
地域別および世界別の細胞解析市場動向、主要企業、市場セグメント、応用分野、市場成長戦略などの分析を含みます。

主な市場セグメント
技術別
フローサイトメトリー
質量分析
次世代シーケンサー(NGS)
ポリメラーゼ連鎖反応(PCR)
その他

アプリケーション別
腫瘍学
免疫学
心臓病学
遺伝子疾患
幹細胞
その他

製品別
消耗品
サービス
機器
ソフトウェア

エンドユーザー別
バイオテクノロジーおよび製薬会社
病院・診断研究所
学術・研究機関
その他

地域別
北米
米国
カナダ
メキシコ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
アジア太平洋
日本
中国
オーストラリア
韓国
インド
その他のアジア太平洋地域
LAMEA
ブラジル
サウジアラビア
南アフリカ
その他の地域

主な市場プレイヤー
○ Agilent Technologies, Inc.
○ Becton, Dickinson and Company
○ Biomerieux SA
○ Bio-Rad Laboratories, Inc. 
○ Danaher Corporation
○ Illumina, Inc.
○ Qiagen N.V.
○ Sartorius AG
○ Standard BioTools Inc.
○ Thermo Fisher Scientific, Inc.

第1章:イントロダクション
第2章:エグゼクティブサマリー
第3章:市場概要
第4章:細胞解析市場、製品別
第5章:細胞解析市場、技術別
第6章:細胞解析市場、用途別
第7章:細胞解析市場、エンドユーザー別
第8章:細胞解析市場、地域別
第9章:競争状況
第10章:企業情報

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic disease
3.4.1.2. Advancement in cell analysis technology
3.4.1.3. Surge in popularity of personalized medicine approach

3.4.2. Restraints
3.4.2.1. High cost of single cell analysis

3.4.3. Opportunities
3.4.3.1. High growth potential of Single cell sequencing

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: CELL ANALYSIS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Services
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Instruments
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Software
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: CELL ANALYSIS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Flow cytometry
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Mass Spectrometry
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Next Generation Sequencing (NGS)
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Polymerase Chain Reaction (PCR)
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: CELL ANALYSIS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Oncology
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Immunology
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Cardiology
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Genetic Disease
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Stem Cells
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
6.7. Others
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis by country
CHAPTER 7: CELL ANALYSIS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Biotechnology and Pharmaceutical Companies
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Hospitals and Diagnostic Laboratories
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Academic and Research Laboratories
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Others
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
CHAPTER 8: CELL ANALYSIS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product
8.2.3. Market size and forecast, by Technique
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product
8.2.6.1.3. Market size and forecast, by Technique
8.2.6.1.4. Market size and forecast, by Application
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product
8.2.6.2.3. Market size and forecast, by Technique
8.2.6.2.4. Market size and forecast, by Application
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product
8.2.6.3.3. Market size and forecast, by Technique
8.2.6.3.4. Market size and forecast, by Application
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product
8.3.3. Market size and forecast, by Technique
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product
8.3.6.1.3. Market size and forecast, by Technique
8.3.6.1.4. Market size and forecast, by Application
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product
8.3.6.2.3. Market size and forecast, by Technique
8.3.6.2.4. Market size and forecast, by Application
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product
8.3.6.3.3. Market size and forecast, by Technique
8.3.6.3.4. Market size and forecast, by Application
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product
8.3.6.4.3. Market size and forecast, by Technique
8.3.6.4.4. Market size and forecast, by Application
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product
8.3.6.5.3. Market size and forecast, by Technique
8.3.6.5.4. Market size and forecast, by Application
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product
8.3.6.6.3. Market size and forecast, by Technique
8.3.6.6.4. Market size and forecast, by Application
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product
8.4.3. Market size and forecast, by Technique
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product
8.4.6.1.3. Market size and forecast, by Technique
8.4.6.1.4. Market size and forecast, by Application
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product
8.4.6.2.3. Market size and forecast, by Technique
8.4.6.2.4. Market size and forecast, by Application
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. Australia
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product
8.4.6.3.3. Market size and forecast, by Technique
8.4.6.3.4. Market size and forecast, by Application
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. South Korea
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product
8.4.6.4.3. Market size and forecast, by Technique
8.4.6.4.4. Market size and forecast, by Application
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. India
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product
8.4.6.5.3. Market size and forecast, by Technique
8.4.6.5.4. Market size and forecast, by Application
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product
8.4.6.6.3. Market size and forecast, by Technique
8.4.6.6.4. Market size and forecast, by Application
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product
8.5.3. Market size and forecast, by Technique
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product
8.5.6.1.3. Market size and forecast, by Technique
8.5.6.1.4. Market size and forecast, by Application
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product
8.5.6.2.3. Market size and forecast, by Technique
8.5.6.2.4. Market size and forecast, by Application
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product
8.5.6.3.3. Market size and forecast, by Technique
8.5.6.3.4. Market size and forecast, by Application
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product
8.5.6.4.3. Market size and forecast, by Technique
8.5.6.4.4. Market size and forecast, by Application
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Agilent Technologies, Inc.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. Becton, Dickinson and Company
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Biomerieux SA
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Bio-Rad Laboratories, Inc. 
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. Danaher Corporation
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.5.7. Key strategic moves and developments
10.6. Sartorius AG
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Illumina, Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. Thermo Fisher Scientific, Inc.
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.9. Qiagen N.V.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
10.10. Standard BioTools Inc.
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. CELL ANALYSIS MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. CELL ANALYSIS MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. CELL ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. CELL ANALYSIS MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GLOBAL CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 07. CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 08. CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 09. CELL ANALYSIS MARKET FOR NEXT GENERATION SEQUENCING (NGS), BY REGION, 2022-2032 ($MILLION)
TABLE 10. CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION (PCR), BY REGION, 2022-2032 ($MILLION)
TABLE 11. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 13. CELL ANALYSIS MARKET FOR ONCOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 14. CELL ANALYSIS MARKET FOR IMMUNOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 15. CELL ANALYSIS MARKET FOR CARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
TABLE 16. CELL ANALYSIS MARKET FOR GENETIC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 17. CELL ANALYSIS MARKET FOR STEM CELLS, BY REGION, 2022-2032 ($MILLION)
TABLE 18. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 19. GLOBAL CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CELL ANALYSIS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
TABLE 21. CELL ANALYSIS MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 22. CELL ANALYSIS MARKET FOR ACADEMIC AND RESEARCH LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 23. CELL ANALYSIS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 24. CELL ANALYSIS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 26. NORTH AMERICA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 27. NORTH AMERICA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. NORTH AMERICA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. NORTH AMERICA CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. U.S. CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 31. U.S. CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 32. U.S. CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. U.S. CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 34. CANADA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. CANADA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 36. CANADA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 37. CANADA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 38. MEXICO CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 39. MEXICO CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 40. MEXICO CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. MEXICO CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. EUROPE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 43. EUROPE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 44. EUROPE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. EUROPE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. EUROPE CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 47. GERMANY CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 48. GERMANY CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 49. GERMANY CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. GERMANY CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. FRANCE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 52. FRANCE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 53. FRANCE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. FRANCE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. UK CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 56. UK CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 57. UK CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. UK CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. ITALY CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. ITALY CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 61. ITALY CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 62. ITALY CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 63. SPAIN CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 64. SPAIN CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 65. SPAIN CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. SPAIN CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF EUROPE CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 68. REST OF EUROPE CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 69. REST OF EUROPE CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF EUROPE CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. ASIA-PACIFIC CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 72. ASIA-PACIFIC CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 73. ASIA-PACIFIC CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 74. ASIA-PACIFIC CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 75. ASIA-PACIFIC CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 76. JAPAN CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 77. JAPAN CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 78. JAPAN CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. JAPAN CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. CHINA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 81. CHINA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 82. CHINA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. CHINA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 84. AUSTRALIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 85. AUSTRALIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 86. AUSTRALIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. AUSTRALIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 88. SOUTH KOREA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 89. SOUTH KOREA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 90. SOUTH KOREA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 91. SOUTH KOREA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 92. INDIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 93. INDIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 94. INDIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 95. INDIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 96. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 97. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 98. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 99. REST OF ASIA-PACIFIC CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 100. LAMEA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 101. LAMEA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 102. LAMEA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 103. LAMEA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 104. LAMEA CELL ANALYSIS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 105. BRAZIL CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 106. BRAZIL CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 107. BRAZIL CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 108. BRAZIL CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 109. SAUDI ARABIA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 110. SAUDI ARABIA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 111. SAUDI ARABIA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 112. SAUDI ARABIA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 113. SOUTH AFRICA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 114. SOUTH AFRICA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 115. SOUTH AFRICA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 116. SOUTH AFRICA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 117. REST OF LAMEA CELL ANALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 118. REST OF LAMEA CELL ANALYSIS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
TABLE 119. REST OF LAMEA CELL ANALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 120. REST OF LAMEA CELL ANALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 121. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 122. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 123. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
TABLE 124. AGILENT TECHNOLOGIES, INC.: SERVICE SEGMENTS
TABLE 125. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 126. AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
TABLE 127. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 128. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 129. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
TABLE 130. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 131. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 132. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 133. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 134. BIOMERIEUX SA: PRODUCT SEGMENTS
TABLE 135. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 136. BIOMERIEUX SA: KEY STRATERGIES
TABLE 137. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
TABLE 138. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
TABLE 139. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
TABLE 140. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
TABLE 141. BIO-RAD LABORATORIES, INC. : KEY STRATERGIES
TABLE 142. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 143. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 144. DANAHER CORPORATION: PRODUCT SEGMENTS
TABLE 145. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 146. DANAHER CORPORATION: KEY STRATERGIES
TABLE 147. SARTORIUS AG: KEY EXECUTIVES
TABLE 148. SARTORIUS AG: COMPANY SNAPSHOT
TABLE 149. SARTORIUS AG: PRODUCT SEGMENTS
TABLE 150. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 151. SARTORIUS AG: KEY STRATERGIES
TABLE 152. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 153. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 154. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 155. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 156. ILLUMINA, INC.: KEY STRATERGIES
TABLE 157. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
TABLE 158. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 159. THERMO FISHER SCIENTIFIC, INC.: SERVICE SEGMENTS
TABLE 160. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 161. QIAGEN N.V.: KEY EXECUTIVES
TABLE 162. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 163. QIAGEN N.V.: PRODUCT SEGMENTS
TABLE 164. QIAGEN N.V.: PRODUCT PORTFOLIO
TABLE 165. QIAGEN N.V.: KEY STRATERGIES
TABLE 166. STANDARD BIOTOOLS INC.: KEY EXECUTIVES
TABLE 167. STANDARD BIOTOOLS INC.: COMPANY SNAPSHOT
TABLE 168. STANDARD BIOTOOLS INC.: PRODUCT SEGMENTS
TABLE 169. STANDARD BIOTOOLS INC.: PRODUCT PORTFOLIO
TABLE 170. STANDARD BIOTOOLS INC.: KEY STRATERGIES

★調査レポート[世界の細胞解析市場2023年-2032年:製品別(消耗品、サービス、機器、ソフトウェア)、技術別(フローサイトメトリー、質量分析、次世代シーケンシング(NGS)、ポリメラーゼ連鎖反応(PCR)、その他)、用途別(腫瘍学、免疫学、心臓病学、遺伝病、幹細胞、その他)、エンドユーザー別(バイオテクノロジー&製薬会社、病院&診断研究所、学術&研究機関、その他)] (コード:ALD23SEP108)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の細胞解析市場2023年-2032年:製品別(消耗品、サービス、機器、ソフトウェア)、技術別(フローサイトメトリー、質量分析、次世代シーケンシング(NGS)、ポリメラーゼ連鎖反応(PCR)、その他)、用途別(腫瘍学、免疫学、心臓病学、遺伝病、幹細胞、その他)、エンドユーザー別(バイオテクノロジー&製薬会社、病院&診断研究所、学術&研究機関、その他)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆